发布时间：2026-05-13 15:31 FY2025 Pipeline Successes Set the Stage for Pivotal Product Launches
Achieved Latest FY2025 Management Guidance
Takeda is Entering a New Era & Transforming for Growth Acceleration



OSAKA, Japan--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the fiscal year 2025 (period ended March 31, 2026). The Company delivered solid results in line with its latest FY2025 Management Guidance, reflecting strong OPEX savings, mitigating revenue headwinds while continuing to invest in future growth.

Key Highlights for FY2025


Revenue decreased by 1.7% YoY at actual exchange rates (AER), resulting from the loss of exclusivity for VYVANSE® which was partially mitigated by Growth and Launch Products. On a Core basis, Revenue decreased by 2.6% at Constant Exchange Rate (CER).

Core Operating Profit increased by 0.8% YoY at AER and declined by 0.9% at CER, protected by OPEX savings, w
=*=*=*=*=*=
当前为第1/23页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页